A double-blind, cross-over patient preference study of frovatriptan versus zolmitriptan for the acute treatment of migraine

Trial Profile

A double-blind, cross-over patient preference study of frovatriptan versus zolmitriptan for the acute treatment of migraine

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2016

At a glance

  • Drugs Frovatriptan (Primary) ; Zolmitriptan
  • Indications Migraine
  • Focus Therapeutic Use
  • Sponsors Menarini
  • Most Recent Events

    • 12 Oct 2016 This trial is completed in Ireland (End date: 2008-11-03) as per European Clinical Trials Database record.
    • 16 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top